Cancer of the ovary is the fifth most commonly diagnosed cancer, and the fourth most common cause of cancer death, in women, in Ontario. While relatively little is known about its aetiology, recent studies have suggested a protective effect of certain surgical procedures, namely hysterectomy, tubal ligation, and unilateral ovariectomy. [1] [2] [3] [4] [5] One hypothesis underlying this protective effect is that of 'screening' for visible ovarian anomalies during the surgical procedure. 6 In order to address this issue, and in particular to determine whether or not a screening protective effect diminishes over time, we have conducted a population-based historical cohort study.
METHODS
The cohort of women was assembled from the records of the Hospital Medical Records Institute (HMRI), which contains hospital discharge data for all inpatient medical procedures performed in Ontario hospitals since April 1979. Same-day surgery records also are included in the file, from April 1990. The HMRI database employs the Canadian Classification of Diagnostic, Therapeutic and Surgical Procedures 7 to classify procedures. We included women who had a tubal ligation, hysterectomy, and/or unilateral ovariectomy and several other gynaecological procedures between April 1979 and March 1993 as identified by HMRI (Table 1 for procedure codes). Records were supplied on magnetic tape by the Ministry of Health (MOH). This HMRI/MOH file contained 1 010 301 individual records, some of which were multiple hospital admissions for the same individual. The file was reviewed for completeness of the data elements: surname, first name, full birth date, and hospital discharge date were Ͼ95% complete; health insurance number and procedure date were 86% and 63% complete, respectively. When a procedure date was not available, the hospital discharge date was used.
Three linkages were conducted: an internal linkage of the HMRI/MOH file; a linkage between that file and the file of all-causes mortality; and finally a linkage with the file containing cancer diagnoses. These linkages were performed using Automatch, 8 and are described below. The first linkage was an internal probabilistic computerized record linkage of the HMRI/MOH file. In this internal linkage, women who had had more than one surgical procedure in the relevant time period (i.e. had at least two unique hospital records) were identified, and each record was assigned the same identifying group number, in an effort to keep all their records together. Excluded from the file were duplicate records, and records which indicated that the woman had had a bilateral ovariectomy. In addition, we excluded records with missing age and/or missing procedure date (after assigning discharge date, if present), records for women who were Ͻ15 years old at the time of the surgical procedure, and records relating to other procedures (e.g. dilatation and curettage).
The second linkage was between the HMRI/MOH file and the all-causes mortality file, which contained death certificate information for all residents of Ontario. This mortality file was obtained from the Registrar General of Ontario, and included deaths occurring between 1978 and 1994. Prior to linkage, the mortality file was reviewed for completeness of its data elements: surname, first name, sex, full birth date, full death date and age were Ͼ99% complete.
The final linkage was to bring into the HMRI/MOH file any diagnoses of ovarian cancer that may have occurred among the members of the cohort. The Ontario Cancer Registry (OCR), a population-based cancer registry, has an estimated completeness Ͼ95% (E J Holowaty, personal communication, 1995). The relevant records (i.e. women diagnosed with ovarian cancer between 1979 and 1993) were extracted from the OCR, and then linked with the HMRI/MOH file. While malignant ovarian cancer was the outcome of interest, the International Classification of Diseases changed that definition in 1988; the latest malignant coding includes what were formerly described as 'borderline malignancy'. Since it was not possible to identify all borderline malignancies which had been diagnosed prior to the coding change (i.e. these pathology reports would not have been submitted routinely to the OCR by pathology departments), a separate code was reserved for the later borderline malignancies, so that their effect in the analysis could be examined.
With the aid of a gynaecological oncologist, the procedures were stratified by whether or not the ovaries could have been seen during the procedure, and by whether or not the procedure resulted in a physical break in the anatomical pathway linking the ovary to the vaginal canal. Thus, for instance, an abdominal hysterectomy would allow the ovaries to be seen, and also would cut the pathway, while a vaginal hysterectomy would cut the pathway, but not allow the ovaries to be seen. Further, tubal ligation always disrupts the pathway, while unilateral ovariectomy allows visualization of the remaining ovary.
Data were analysed using a person-years approach. Person-years at risk were accumulated until death, removal of both ovaries, a diagnosis of ovarian cancer, or the end of the study period (31 December 1993), whichever came first. We excluded women whose surgical procedure was within 6 months of, or followed, the diagnosis of cancer. The data in the OCR were used to estimate expected numbers of events. Expected events were calculated by applying age-, calendar period-, and site-specific cancer rates to person-years accumulated in the cohort, within broad age groupings (15-24, 25-44, 45-64, 65+ years), calendar periods (1979-1983, 1984-1988, 1989-1993) , and length of follow-up (6 months-1.9 years, 2.0-4.9 years, 5.0-9.9 years, 10+ years) for each of the surgical procedures. Certain subanalyses also included finer categories for length of follow-up, and age group/follow-up cross-classification. Primary data analysis involved the comparison of the observed to the expected number (O/E) of ovarian cancers. Person-years were calculated from the time of the surgical procedure (i.e. tubal ligation, hysterectomy, or unilateral ovariectomy), among women who only had that procedure. These were termed 'single procedure' subcohorts. Also analysed were subcohorts which included women having had the first of the three procedures, regardless of the occurrence of any subsequent procedures; these were termed 'multiple procedure' subcohorts. The three subcohort analyses were repeated after exclusion of the borderline malignancies from the SURGERY AND OVARIAN CANCER 711 outcome definition, and the recalculation of the personyears accumulated. Finally, analysis was stratified by whether or not the ovaries were seen at the time of the surgical procedure, and whether the ovarian pathway was disrupted. The three single-procedure subcohorts were combined for this analysis because not all of the three subcohorts had person-years in each of the strata. It was assumed that the observed number of events arose from a Poisson distribution, with the mean equal to the expected number of events. Reported P-values are two-tailed, and represent the probability of a result as extreme as, or more extreme than, the observed number of events. P-values have been estimated by doubling the one-sided P-value and are, therefore, conservative.
RESULTS
The HMRI/MOH file contained 1 010 301 records; exclusion of ineligible or duplicate records, and internal linkage of the file, yielded 399 777 individuals in the single procedure subcohorts. Of these, 251 907 were in the tubal ligation subcohort, 129 495 in the hysterectomy subcohort, and 18 375 in the unilateral ovariectomy subcohort. The number of person-years and cancer events are shown in Table 2 , for the three subcohorts. Table 3 displays the results for the three subcohorts by length of follow-up. There is a strong protective effect among those women who had a tubal ligation, ranging between 0.69 and 0.36. This effect is evident, and statistically significant, at all follow-up intervals. Hysterectomy also was associated with a protective effect for ovarian cancer. The O/E ratio was approximately 0.75 for each follow-up interval, and was statistically significant for all but the longest time. Finally, and in contrast, unilateral ovariectomy was associated with increased risk of ovarian cancer early in the follow-up period (O/E = 3.83 for 6 months to 2 years of follow-up). With increasing length of follow-up, the O/E declined toward unity (O/E = 0.90 for 10+ years of follow-up).
The results by age at, and year of, surgical procedure are shown for the three subcohorts in Tables 4 and 5 , respectively. As in Table 3 , there is a general pattern of a protective effect for women undergoing tubal ligation or hysterectomy, and an increased risk among those women undergoing unilateral ovariectomy. This pattern is evident in each of the four age groups (Table 4 ) and in each of the three calendar periods (Table 5) . Among the multiple procedure subcohorts, the results (not shown) were the same as those reported above for the single procedure subcohorts, although the number of person-years in these latter subcohorts was larger.
'Seeing' and 'not seeing' the ovaries during the surgical procedure were both associated with a significantly decreased risk of subsequent ovarian cancer (O/E = 0.70 and 0.76, respectively). Similarly, the O/E ratios were 0.67 for abdominal and 0.76 for vaginal hysterectomy. A break in the ovarian pathway was associated with a similar statistically significantly decreased risk (O/E = 0.65). If there were no break in the pathway, which would occur primarily among women having had unilateral ovariectomy, the risk of ovarian cancer was significantly increased (O/E = 1.64). Exclusion of borderline ovarian malignancies did not alter the results reported above, either in the complete single-procedure subcohorts or in the combined subcohorts stratified by ovary visualization or pathway disruption (data not shown).
DISCUSSION
This population-based cohort study adds to the growing corpus of data regarding the protective effect of a number of reproductive surgical procedures on ovarian cancer risk. [1] [2] [3] [4] [5] [10] [11] [12] Ovarian cancer occurrence was generally substantially reduced, compared to populationbased expected frequencies, in two of the three surgical subcohorts. While a small cohort study of tubal ligation reported increased risk of ovarian cancer, 13 our results are consistent with the results of the only other large cohort study to assess the relationship between tubal ligation or hysterectomy and the risk of ovarian cancer. 5 That study reported an inverse association between these two surgical procedures and ovarian cancer risk, which persisted after adjustment for covariates. It did not examine unilateral ovariectomy. The inverse association was maintained through 15 years of follow-up for the hysterectomy group (no data were available for the tubal ligation group), although the protective effect was not statistically significant beyond 9 years of follow-up. Our data also provide evidence for a longterm protective effect, statistically significant through the longest period of follow-up in the tubal ligation subcohort, and unaffected by age at, or date of, procedure. Our divergent results for unilateral ovariectomy (i.e. increased rather than decreased risk) are not comparable to the literature, as other studies have not examined this subgroup.
While the study presented here cannot provide evidence for a mechanism by which certain surgical procedures might protect against ovarian cancer (i.e. whether physiological or physical), it can shed some light on the hypothesis that the protection arises from a 'screening' effect due to the selective removal of ovarian cancers from the cohorts and hence the 'false' reduction in subsequent incidence of ovarian cancers observed in those cohorts. 6 The hypothesis would suggest that the protective effect would diminish with time since surgical procedure. The data presented here are completely inconsistent with such a screening effect. The fact that the protective effect is being seen among women undergoing each of the methods of hysterectomy (i.e. that which allows a close examination of the ovaries [abdominal] and that which does not [vaginal] ), 14 lends credence to the conclusion that the protective effect is not artifactual (e.g. due to screening). A priori, the possibility of detection bias was considered: excluded from analysis were any cancers diagnosed within 6 months of the surgical procedure. Our data do not indicate this bias, however, except perhaps in the unilateral ovariectomy subcohort, in which increased risk was evident in the early follow-up intervals, but not subsequently. Since no stage information was available on these tumours, it is not known whether or not the ovarian cancers detected within a few years of surgery were, in fact, tumours of earlier stage than those detected after 5 years of follow-up. We also have no information on potential confounding factors such as use of oral contraceptives and parity. While nonadjustment for these factors might yield a biased estimate of risk, it is unlikely to have accounted for the entire protective effect.
While it is possible that out-migration could have had some impact on the data shown here; migration rates out of Ontario are approximately 0.8% per year for all ages and both sexes combined. 15 For women of the ages included in the present study, we have estimated the out-migration rate to be approximately 70% of this overall rate; this migration rate would have a negligible affect on the O/E reported here. In addition, the inclusion of women with bilateral ovariectomy in the denominator of the rate may lead to some underestimation of the expected frequency and thus an overestimate of the protective effect. Given that there are only approximately 7050 women who have had bilateral ovariectomy per year, in an Ontario population of nearly 4 million women у15 years, we anticipate this bias to be very small.
The data consistently show the effect of length of follow-up to be associated with a decreased risk in the O/E ratio for tubal ligation and hysterectomy. This, together with the lack of effect in the unilateral ovariectomy subcohort, suggest that some effect of the surgical procedure itself (whether it be the physical destruction of a carcinogen's pathway to the ovary, or some biochemical change associated with the alteration of the reproductive organs, or both mechanisms) is involved in what appears to be a real and lasting protection against the occurrence of ovarian cancer.
